AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR 2ND OR GREATER COMPLETE REMISSION OF ACUTE MYELOID-LEUKEMIA AND ACUTE LYMPHOBLASTIC-LEUKEMIA

Twenty patients with acute leukaemia in second or greater complete rem ission have undergone autologous bone marrow transplantation (ABMT) in our centre. Twelve patients had acute myeloid leukaemia (AML) and eig ht patients had acute lymphoblastic leukaemia (ALL). Six of the patien ts treated for AML remain in CR. Of the eight patients with ALL, all h ave died within one year of transplantation. In the patients with AML there was no relationship between the duration of previous CR and outc ome of ABMT.